CASE Op-Ed, RealClear Health: New Cures Coming From Value-Based Outcome Medicine
February 1, 2019 Matthew Kandrch – President, CASE https://bit.ly/2GgtKFJ There is no question America’s healthcare system is too costly. We spend $3.3...
CASE Op-Ed, RealClear Markets: Under-the-Radar Issues That Could Affect the 2019 Economy
January 30, 2019 https://bit.ly/2Sb45ol Gerard Scimeca – Chairman CASE From an economic growth perspective, 2018 was an exceptional year....
The Problem With Price Caps: Why CMS Should Rethink Its Part B Proposal
This week, we submitted comments to Health and Human Services (HHS) Secretary Alex Azar, urging him to reevaluate and abandon...
CASE Submits Comments Urging Sec. Azar to Protect Medicare Part B
December 18, 2018 Dear Secretary Azar: Consumer Action for a Strong Economy (CASE)represents the interests of all American consumers by...
Tell Congress and HHS To Protect Part B
World AIDS Day: A Warning On Socialized Healthcare Systems
On Saturday, the world recognized World AIDS Day. Since it was first recognized as a cause of death in the...
Hospital Consolidation Driving Up Prices For Consumers
On November 6, voters consistently identified healthcare as the number one issue they were concerned about. Put a different way:...
Government Plan on Drug Pricing Ads Won’t Help Consumers
Almost everyone agrees patients should know what their medicines cost them, and that drug pricing should be made more clear...
“New NAFTA” Is Strong Medicine for Creating Better Healthcare for All Americans
Almost all of Washington seems to have an opinion about the new trade deal the Trump Administration struck with Canada...
CASE OP-Ed – InsideSources: AARP Ads Against Drug Makers Driven by Self-Serving Profit Motive
Matthew Kandrach – President, CASE October 9, 2018 – https://bit.ly/2Oihkm5 Recent polling suggests that health care is still very much at the...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/